|
000
| 01400nam 2200325zi 4500 |
|---|
| 001 | 9.901219 |
|---|
| 003 | CaOODSP |
|---|
| 005 | 20221107175620 |
|---|
| 006 | m o d f |
|---|
| 007 | cr cn||||||||| |
|---|
| 008 | 210629t20212020onca o f000 0 eng d |
|---|
| 020 | |a9780660394039 |
|---|
| 040 | |aCaOODSP|beng|erda|cCaOODSP |
|---|
| 043 | |an-cn-qu |
|---|
| 086 | 1 |aNR16-364/2021E-PDF |
|---|
| 245 | 00|aClinical Trial Material Facility : |boverview. |
|---|
| 264 | 1|a[Ottawa] : |bNational Research Council Canada = Conseil national de recherches Canada, |c[2021] |
|---|
| 264 | 4|c©2020 |
|---|
| 300 | |a1 online resource (2 unnumbered pages) : |bcolour illustrations |
|---|
| 336 | |atext|btxt|2rdacontent |
|---|
| 337 | |acomputer|bc|2rdamedia |
|---|
| 338 | |aonline resource|bcr|2rdacarrier |
|---|
| 500 | |aIssued also in French under title: Infrastructure de production de matériel pour essais cliniques : aperçu. |
|---|
| 530 | |aIssued also in printed form. |
|---|
| 650 | 0|aDrug factories|zQuébec (Province)|zMontréal. |
|---|
| 650 | 0|aVaccines|xBiotechnology|zQuébec (Province)|zMontréal. |
|---|
| 710 | 2 |aNational Research Council Canada, |eissuing body. |
|---|
| 775 | 08|tInfrastructure de production de matériel pour essais cliniques : |w(CaOODSP)9.901218 |
|---|
| 776 | 0#|tClinical Trial Material Facility : |w(CaOODSP)9.901217 |
|---|
| 856 | 40|qPDF|s363 KB|uhttps://publications.gc.ca/collections/collection_2021/cnrc-nrc/NR16-364-2021-eng.pdf |
|---|